Jardiance is the single-ingredient product, while Synjardy pairs empagliflozin with metformin
semaglutide and 0.79 [0.57;1.11] for once-daily oral semaglutide)
Many patients experience substantial weight loss over 6-12 months, with an average reduction of 10-20% of their starting weight, depending on lifestyle habits and individual response to treatment

News Browse all news Symrise reports solid H1 2026 performance with accelerating growth momentum in Q2 Corporate | Financial Organic sales growth accelerated to 4.5% in Q2 2026 (2.0% in H1 2026) Adjusted EBITDA of 553 million and 21.8% adjusted EBITDA margin Adjusted Business Free Cash Flow margin up 450 bps to 13.7% of sales Planned acquisition of Floral Concept will strengthen position in Premium Naturals Full year 2026 outlook reaffirmed Facts & figures Symrise AG share price 89.30 0.20 (0.22%) A case for investment Corporate Report 2025 Events Browse all events Financial Sep 8, 2026 Global Consumer Staples Conference, Boston (Barclays) Add to calendar Financial Sep 9, 2026 Roadshow, New York Add to calendar Financial Sep 21, 2026 German Corporate Conference, Munich (Berenberg/Goldman & Sachs) Add to calendar Financial Sep 28, 2026 Pre-Close Aide-Mmoire Q3 2026 Add to calendar Financial Sep 29, 2026 Quiet Period Add to calendar Financial Oct 29, 2026 Quarterly Statement Q3 2026 Add to calendar Your career at Symrise create with us
